EEF1A1 and bacterial infectious disease: Blockade of this interaction, either with nucleolin-binding pseudopeptide HB-19 or with anti-EF-Tu Ab, results in inhibition of LVS bacteria binding to human THP-1 cells and subsequent inhibition of bacterial infection.